Stock screenerAll disclosures →
EDGAR →
AMRX
Conviction 80HealthcareScan · Thu, Sep 24, 2026Mat hold
Amneal Pharmaceuticals, Inc. (AMRX) closed at $19.81 (+2.48%) on Sep 24, 2026. Its latest daily candle is a mat hold. Price is above its 50-day and above its 200-day moving average. RSI(14) 64, RS Rating 94, -1.7% from its 52-week high, +56.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
AMRX$19.81+2.48%
ResistanceSupportVol 14Insider sell2
Vol MA14 2.77M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price19.81
Change+2.48%
Gap+0.18%
Rel volume0.71×
Avg volume2.48M
Avg $ vol45.5M
SMA 2018.00
SMA 5018.04
SMA 20014.77
Price vs 50+9.79%
Price vs 200+34.15%
MA stackbullish
50/200 cross—
Supertrendup · 17.39
RSI (14)64
MACD hist0.27
MACD crossbull · 5d
Stoch %K / %D70 / 65
ADX (14)25
+DI / −DI33 / 15
RSI divergence—
MACD divergence—
ATR %4.17%
ADR %4.12%
52w high20.16
52w low9.60
From 52w high-1.74%
Above 52w low+106.35%
New 52w highNo
SqueezeOff
Bollinger width22.02%
%B0.96
Donchian pos70.42%
Donchian high21.18
Donchian low16.56
AVWAP (52w high)19.74
vs AVWAP high+0.38%
AVWAP (52w low)14.26
vs AVWAP low+38.93%
OBV trendUp
Chaikin MF (20)0.10
Today vs 20d0.71×
Avg vol (14d)2.77M
Avg vol (20d)2.48M
Avg $ vol (20d)45.5M
Market cap6.33B
RS Rating94 / 99
RS 3m (vs SPY)+9.89%
RS 6m (vs SPY)+44.76%
RS line new highNo
Trend template8/8
Technical rank91.4
1 week+8.37%
1 month+10.55%
3 months+14.38%
6 months+61.58%
1 year+101.32%
YTD+56.48%
P/E87.80
P/B191.57
P/S2.10
P/FCF23.44
EPS0.2200
Div yield—
ROE218.20%
ROA1.91%
Debt/Eq77.83
Current2.20
EV/EBITDA—
Gross margin36.88%
Net margin2.39%
Rev growth8.05%
EPS growth161.65%
Price target22.17
Target upside11.91%
Analyst ratingBuy
Institutional56.83%
Ent. value8.77B
Revenue796.2M
Net income57.66M
Gross profit334.51M
Free cash flow269.93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out319.02M
Employees8.5K
ListedMon, May 7, 2018
Free float169.55M
Float %53.2%
Short interest10.57M
Days to cover7.4d
Short volume60.9%
Squeeze score51 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.27 vs $0.24
Last surprise+12.5% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank91.4 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmMat hold
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Oppenheimer initiates Amneal Pharmaceuticals stock with outperform ratingInvesting.com · Wed, Sep 23, 2026
- Amneal: Even My Bull Case Barely Justifies $20/Share (NASDAQ:AMRX)Seeking Alpha · Tue, Sep 22, 2026
- Amneal Pharmaceuticals Inc (AMRX) Shares Surge 7.8% -- What GF SGuruFocus · Tue, Sep 22, 2026
- Why Is Amneal (AMRX) Stock Rocketing Higher TodayYahoo Finance · Tue, Sep 22, 2026
- Amneal (NASDAQ: AMRX) director gifts 20,445 shares to trust he overseesStock Titan · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in AMRX
No recent disclosed trades by Congress in AMRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AMRX · open-market 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BUCHI J KEVIN Director · Class A Common Stock · 2026-09-17 | Gift | 20.45K | — | 2026-09-17 | 2026-09-21 |
BUCHI J KEVIN Director · Class A Common Stock · 2026-09-11 | Exercise | 20.45K | $295K | 2026-09-11 | 2026-09-14 |
BUCHI J KEVIN Director · Stock Option · 2026-09-11 | Exercise | 20.45K | — | 2026-09-11 | 2026-09-14 |
BOYER ANDREW S Executive Vice President · Class A Common Stock · 2026-09-01 | Gift | 80K | — | 2026-09-01 | 2026-09-02 |
BOYER ANDREW S Executive Vice President · Class A Common Stock · 2026-08-21 | Gift | 152.43K | — | 2026-08-21 | 2026-08-25 |
Kiely John Director · Class A Common Stock · 2026-08-13 | Sell | 50K | $882K | 2026-08-13 | 2026-08-14 |
Kiely John Director · Class A Common Stock · 2026-08-13 | Gift | 10K | — | 2026-08-13 | 2026-08-14 |
Daly Jason B. EVP, Chief Legal Officer · Class A Common Stock · 2026-08-12 | Sell | 210K | $3.7M | 2026-08-12 | 2026-08-13 |
Shah Nikita Executive Vice President · Class A Common Stock · 2026-08-12 | Sell | 146.4K | $2.6M | 2026-08-12 | 2026-08-13 |
Daly Jason B. EVP, Chief Legal Officer · Class A Common Stock · 2026-08-11 | Sell | 6.61K | $117K | 2026-08-11 | 2026-08-13 |
SEC filings
EDGAR filings in AMRX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.